GlassScriptPhysician profile
Ryan P Edmonds
NPI 1093029522
$7,452.36
in general payments reported to CMS, 2019-2025
17 companies · $2,202 in 2025
The $2,202 reported for 2025 was more than what 97% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $215 · 2020: $1,552 · 2021: $2,572 · 2022: $277 · 2023: $396 · 2024: $238 · 2025: $2,202.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,533 · Travel and Lodging: $1,303.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,532.59 |
| Travel and Lodging | $1,303.13 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bausch & Lomb, A Division of Bausch Health US, LLC | $3,979.97 | 2019-2021 | |
| Coopervision INC. | $1,922.20 | 2019-2025 | Onefit Contact Lens, Myday Contact Lens, Paragon Crt |
| Alcon Vision LLC | $368.49 | 2021-2025 | Clareon Panoptix Pro, Precision7 |
| Bausch & Lomb Americas INC. | $222.96 | 2023 | Infuse, Miebo |
| Johnson & Johnson Vision Care, INC. | $171.12 | 2019-2023 | Acuvue |
| Visioneering Technologies, INC. | $128.78 | 2019-2025 | |
| Allergan, INC. | $112.00 | 2022 | |
| Oyster Point Pharma, INC. | $102.30 | 2022-2023 | Tyrvaya |
| Lkc Technologies, INC. | $98.98 | 2024 | |
| Tarsus Pharmaceuticals, INC. | $93.48 | 2024 | Xdemvy |
| Horizon Therapeutics Plc | $75.92 | 2021 | |
| Abbvie INC. | $62.78 | 2023 | Vuity |
| Synergeyes, INC. | $31.65 | 2022 | |
| Dompe US, INC. | $29.28 | 2025 | Oxervate |
| Carl Zeiss Meditec Ag | $19.40 | 2020 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Carl Zeiss Meditec, INC. | $17.24 | 2020 | |
| Biotissue Holdings INC. | $15.81 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ryan Edmonds listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.